Specific immunological detection of the (V+C)- fibronectin isoform

Matrix Biology

Volumn 21, Issue 5, 2002, Pages 393-398

  Burton Wurster, Nancy ^a   Chen, Hao ^a   Gendelman, Rina ^a   Jackson, Michael L ^a   Gagliardo, Lucille F ^a   Gu, Da Nian ^a   Zelko, Russell R ^b   Lust, George ^a   MacLeod, James N ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b Cayuga Medical Center   (United States)

Author keywords

(V+C) fibronectin; Biomarker; Cartilage; Monoclonal antibody; Osteoarthritis; Synovial fluid

Indexed keywords

EPITOPE; FIBRONECTIN; ISOPROTEIN; MONOCLONAL ANTIBODY;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CARTILAGE; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SYNOVIAL FLUID;

ANIMALS; ANTIBODIES, MONOCLONAL; CARTILAGE; CROSS REACTIONS; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC TECHNIQUES; PROTEIN ISOFORMS; SYNOVIAL FLUID;

MAMMALIA;

EID: 0036701557     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(02)00033-1     Document Type: Article

References (12)

1. - fibronectin isoform exists primarily in homodimeric and monomeric configurations. Biochem. J. 341:1999;555-561.
2. Burton-Wurster N., Lust G. Deposition of fibronectin in articular cartilage of canine osteoarthritic joints. Am. J. Vet. Res. 46:1985;2542-2545.
3. Castle A.M., Schwarzbauer J.E., Wright R.L., Castle J.D. Differential targeting of recombinant fibronectins in AtT-20 cells based on their efficiency of aggregation. J. Cell Sci. 108:1995;3827-3837.
4. Chen H., Gu D.N., Burton-Wurster N., MacLeod J.N. Absence of the 1-10 protein segment mediates restricted dimerization of the cartilage-specific fibronectin isoform. J. Biol. Chem. 277:2002;20095-20103.
5. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1993;1079-1091.
6. Hari S.P., McAllister H., Chuang W.-L., Christ M.D., Rabenstein D.L. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin. Biochemistry. 39:2000;3763-3773.
7. Jones K.L., Brown M., Ali S.Y., Brown R.A. An immunohistochemical study of fibronectin in human osteoarthritic and disease free articular cartilage. Ann. Rheum. Dis. 46:1987;809-815.
8. MacLeod J.N., Burton-Wurster N., Gu D.N., Lust G. Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15 and I-10 protein segments. J. Biol. Chem. 271:1996;18954-18960.
9. Schwarzbauer L.E., Mulligan R.C., Hynes R.O. Efficient and stable expression of recombinant fibronectin polypeptides. Proc. Natl. Acad. Sci. USA. 84:1987;754-758.
10. Sechler J.L., Takada Y., Schwarzbauer J.E. Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J. Cell Biol. 134:1996;573-583.
11. Sharma A., Askari J.A., Humphries M.J., Jones E.Y., Stuart D.I. Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J. 18:1999;1468-1479.
12. Zhang D., Burton-Wurster N., Lust G. Alternative splicing of ED-A and ED-B sequences of fibronectin pre-mRNA differs in chondrocytes from different cartilaginous tissues and can be modulated by biological factors. J. Biol. Chem. 270:1995;1817-1822.